3Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection : New estimates of age-specific antibody to HCV seroprevalence [J]. Hepatology, 2013, 57(4) :1333-1342.
4Loggi E, Cursaro C, Scuteri A, et al. Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C [J]. J Clin Virol, 2013,56(3):291- 295.
5Yu JW, Sun LJ, Liu W, et al. Hepatitis C virus core protein induces hepatic metabolism disorders through down- regulation of the SIRT1-AMPK signaling pathway [J]. Int J Infect Dis, 2013,17, (7) : 539-545.
6Cardin R, Piciocchi M, Sinigaglia A, et al. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma [J]. BMC Cancer, 2012, 12( 1 ) : 177.
7Cross TJ, Quaglia A, Hughes S, et al. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection [Jl. J Viral Hepat, 2009,16 (7) : 492-499.
8Gala S, Carenzi S, Barilli AL, at al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis [J]. J Hepatol,2011, (1)54: 64-71.
9Shah SR, Patel K, Marcellin P, et al. Steatosis is an independent predictor pf relapse following rapid virologic response in patients with HCV genotype3 [J]. Clin Gastroenterol Hepatol, 2011,9(8) :688-693.
10Piodi A, Chouteau P, Lerat H, et al. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype sequences and relationship with steatosis [J]. Hepatology, 2008,48 (1):16-27.
